# South Korea Occlusion Devices Market

> South Korea Occlusion Devices Market Research Report: Size, Share, Trend Analysis By Product (Occlusion Removal Devices, Embolization Devices, Tubal Occlusion Devices, Support Devices), By Applications (Neurology, Cardiology) and By End Users (Hospitals & Clinics) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.29%
- **2024:** $ 92.14 Million
- **2025:** $ 97.01 Million
- **2035:** $ 162.5 Million
- **Key Players:** Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Terumo Corporation (JP), B. Braun Melsungen AG (DE), Johnson & Johnson (US), Stryker Corporation (US), Cook Medical (US)

**Report ID:** MRFR/HC/53245-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/south-korea-occlusion-devices-market-55009

---

## Market Summary

## **South Korea Occlusion Devices Market Overview**

As per MRFR analysis, the South Korea Occlusion Devices Market Size was estimated at 52 (USD Million) in 2023. The South Korea Occlusion Devices Market Industry is expected to grow from 54.5(USD Million) in 2024 to 82 (USD Million) by 2035. The South Korea Occlusion Devices Market CAGR (growth rate) is expected to be around 3.784% during the forecast period (2025 - 2035).

**Key South Korea Occlusion Devices Market Trends Highlighted**

In South Korea, the occlusion devices market is experiencing significant growth driven by the increasing prevalence of cardiovascular diseases and a rising aging population. The South Korean government has been making efforts to improve healthcare infrastructure, which encourages the adoption of advanced medical technologies, including occlusion devices.

Additionally, there is an ongoing commitment to expand health insurance coverage for innovative medical treatments, making these devices more accessible to patients. Recent trends in South Korea emphasize the development of minimally invasive procedures, with occlusion devices being central to these advancements.These devices are becoming increasingly popular among medical practitioners because of their efficiency and faster recovery time when compared to traditional surgical methods.

This change is evident in the educational programs that incorporate the teaching of occlusion devices, facilitating mastery among caregivers. The opportunities that can be looked into include the possible combination of occlusion devices with other digital health technologies to improve patient monitoring and therapeutic results. In South Korea, the growth of telemedicine opens new possibilities for remote consultation and follow-up care, increasing patient access to care while enabling providers to more readily assess device use and effectiveness.

Also, local manufacturers are focusing on R&D to design innovative devices tailored to the unique needs of the South Korean patient population. Market trends also show a growing awareness among patients regarding preventative healthcare, leading to an increase in screening and early intervention strategies that significantly impact the usage of occlusion devices. As healthcare technologies continue to evolve, the South Korean occlusion devices market is positioned for future growth and innovation.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**South Korea Occlusion Devices Market Drivers**

**Increasing Incidence of Cardiovascular Diseases**

The rising rate of cardiovascular diseases significantly drives growth in the South Korea [Occlusion Devices Market](../../../reports/occlusion-devices-market-5934) Industry. According to the Statistics Korea report, heart disease remains one of the leading causes of mortality, accounting for over 30% of fatalities in recent years. The Korean Cardiovascular Society has also reported a steady increase in the prevalence of coronary artery disease, with estimates suggesting that approximately 1.2 million individuals in South Korea are living with some form of heart disease.

This alarming trend requires innovative solutions such as occlusion devices to reduce complications related to cardiovascular conditions. Established players in the industry, such as St. Jude Medical, are investing heavily in Research and Development to create advanced occlusion devices tailored to meet the specific needs of South Korean patients, indicating strong market potential.

**Technological Advancements in Medical Devices**

Throughout South Korea, significant advancements in medical technology are facilitating the growth of the South Korea Occlusion Devices Market Industry. The Ministry of Health and Welfare has initiated programs promoting the adoption of state-of-the-art medical technologies, which has resulted in the emergence of innovative occlusion devices.

For instance, minimally invasive procedures are increasingly becoming the standard of care, with specialized occlusion devices achieving a 30% lower complication rate, making them more favorable for both physicians and patients.Major companies, including Medtronic, are leading the charge with cutting-edge products that underscore the importance of such technologies in modern medicine.

**Growing Aging Population**

South Korea is experiencing a rapid increase in its aging population, which significantly influences the South Korea Occlusion Devices Market Industry. According to the Korean Statistical Information Service, the proportion of individuals aged 65 and older is projected to rise from 15.7% in 2020 to over 24% by 2035. This demographic shift is associated with a heightened risk for many health issues requiring occlusion devices, such as vascular diseases and stroke.

The Korean Geriatric Society believes that as the number of elderly patients rises, the demand for specialized occlusion devices will also grow. Establishments like Samsung Medical Center are adapting their services and technologies to cater specifically to this growing elderly demographic, highlighting the market's responsiveness to demographic changes.

**Enhanced Patient Awareness and Healthcare Accessibility**

There is a marked increase in patient awareness regarding health issues and available treatment options in South Korea, positively impacting the South Korea Occlusion Devices Market Industry. Campaigns led by the Korean Medical Association have successfully educated the public about cardiovascular health and the importance of timely medical intervention, leading to a notable rise in patient visits for diagnosis and treatment.

Reports reflect a 20% increase in outpatient visits for heart-related concerns since 2018.This shift towards proactive healthcare creates a greater demand for occlusion devices. Furthermore, the government's efforts to enhance healthcare accessibility, including the expansion of health insurance coverage for occlusion devices, reinforce the growth prospects of this market.

**South Korea Occlusion Devices Market Segment Insights**

**Occlusion Devices Market Product Insights**

The South Korea Occlusion Devices Market is characterized by a diverse range of products designed to address various medical needs related to occlusion therapies. Prominent within this segment are Occlusion Removal Devices, which are crucial for removing obstructions in vessels or ducts and thus play a vital role in a variety of surgical procedures.

These devices are significant as they aid in minimizing complications and enhancing recovery time for patients. Embolization Devices hold a pivotal position as well, serving to block blood flow to specific areas, which is critical in the treatment of tumors and vascular malformations.Their growing application in minimally invasive surgeries highlights the shift towards less invasive treatment options that are appealing to both patients and healthcare providers.

Tubal Occlusion Devices are also noteworthy; they are vital in contraceptive procedures, offering women a permanent option for family planning, which aligns with the increasing awareness and demand for reproductive health solutions in South Korea. Additionally, Support Devices complement these occlusion treatments by ensuring more effective and safer procedures through stabilization and support during surgery.

The innovations and technological advancements in these devices reflect the broader trend of increased investment in the healthcare sector in South Korea as the government continues to prioritize improving patient care and treatment outcomes. As the South Korea Occlusion Devices Market evolves, the interplay of these various product types will be instrumental in catering to the needs of a growing and aging population while also addressing the complexities of modern healthcare delivery.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Occlusion Devices Market Application Insights**

The South Korea Occlusion Devices Market, focused on the Application segment, showcases a crucial role in enhancing patient care and treatment outcomes. This market is primarily driven by advancements in medical technologies, increasing prevalence of cardiovascular diseases, and rising awareness regarding neurological disorders. In the realm of Neurology, occlusion devices are vital for treating conditions such as aneurysms and arteriovenous malformations, significantly improving patient survival rates and quality of life.

Similarly, the Cardiology segment plays a significant role in addressing critical conditions like coronary artery disease, where occlusion devices, such as stents, are essential for restoring proper blood flow.As the healthcare framework in South Korea evolves, with its robust infrastructure and emphasis on Research and Development, these applications are poised for further growth.

The increasing demand for minimally invasive procedures and innovative treatment options presents significant opportunities for companies within this sector, bolstered by supportive government initiatives aimed at enhancing healthcare services and medical device capabilities. The continuous focus on improving healthcare outcomes ensures that the Application segment remains at the forefront of advancements in the South Korea Occlusion Devices Market.

**Occlusion Devices Market End User Insights**

The End User segment of the South Korea Occlusion Devices Market is prominently characterized by the critical roles of hospitals and clinics in patient care and treatment procedures. As vital components of the healthcare ecosystem, these facilities are at the forefront of implementing occlusion devices, which are essential for various medical applications such as vascular surgeries, interventional radiology, and cardiology.

The integration of advanced occlusion devices in these medical settings significantly enhances the efficacy of treatment protocols and patient outcomes.Furthermore, the rise in surgical procedures alongside a growing incidence of vascular diseases contributes greatly to the demand from hospitals and clinics, ensuring their pivotal role in the South Korea Occlusion Devices Market.

The presence of a robust healthcare infrastructure and skilled medical professionals further propels this industry's growth, positioning the hospital and clinic segment as a dominant force within the overall market. This segment is anticipated to continue evolving with ongoing technological advancements and increasing investments in healthcare, ultimately aligning with South Korea's goal of becoming a leader in innovative medical solutions.

**South Korea Occlusion Devices Market Key Players and Competitive Insights**

The South Korea Occlusion Devices Market showcases a dynamic landscape characterized by a mix of both established players and emerging companies, positioning itself as a vital segment within the broader medical devices industry. The demand for occlusion devices, primarily driven by the increase in surgical procedures such as laparoscopic operations and endovascular surgeries and the growing prevalence of diseases necessitating these interventions, has shaped an intensely competitive atmosphere. Market players continuously strive to innovate and expand their product offerings, responding to regulatory changes and heightened patient care demands.

The advancements in technology have facilitated the development of more effective, minimally invasive, and user-friendly occlusion devices, which has become pivotal in gaining a competitive edge. Understanding the competitive landscape, therefore, requires a close examination of key industry players impacting the market dynamics.

Medtronic holds a significant position in the South Korea Occlusion Devices Market, leveraging its extensive portfolio and established presence in the medical technology sector. Known for its commitment to innovation, Medtronic provides a variety of occlusion solutions tailored to address different clinical needs, which sets it apart from other competitors.

The company's strengths are highlighted by its robust research and development capabilities that fuel technological advancements in device manufacturing. Medtronic's strong distribution network ensures the widespread availability of its products in South Korea, fostering trust and reliability among healthcare professionals. Furthermore, strategic partnerships and collaborations further enhance its market presence, allowing for the rapid adoption of advanced solutions to cater to the challenges faced in surgical procedures.

Aesculap has made a notable impact within the South Korea Occlusion Devices Market by focusing on high-quality surgical instruments and medical devices, including specialized occlusion products. The company's key strengths lie in its commitment to precision engineering and the continuous evolution of its product offerings to meet the demands of modern surgery. Aesculap's presence in South Korea is strengthened by its well-established distribution channels and strong relationships with healthcare providers.

Moreover, the company has successfully integrated various mergers and acquisitions to expand its footprint, allowing for enhanced capabilities and broader product ranges. By prioritizing customer satisfaction and adhering to high standards of safety and efficacy, Aesculap solidifies its competitive position in the market, emphasizing its dedication to supporting healthcare professionals in their critical work.

**Key Companies in the South Korea Occlusion Devices Market Include**

- Medtronic
- Aesculap
- LivaNova
- Cook Medical
- Abbott Laboratories
- Terumo Corporation
- Smith & Nephew
- Johnson & Johnson
- C. R. Bard
- B.Braun Melsungen AG
- Philips
- Boston Scientific Corporation
- Stryker Corporation
- Medtronic Navigation
- Cardinal Health

**South Korea Occlusion Devices Market Industry Developments**

In recent months, the South Korea Occlusion Devices Market has experienced notable developments and dynamics influencing its growth. Companies such as Medtronic, Aesculap, and Johnson and Johnson have been focusing on innovative product lines and technologies tailored for occlusion solutions. For instance, in June 2023, Medtronic announced an expansion of its product range specifically targeting vascular occlusion, which is expected to enhance treatment outcomes in the region.

Additionally, in August 2023, updates from Cook Medical and LivaNova highlighted advancements in device manufacturing processes, aiming to improve efficiency and patient safety. The market valuation for occlusion devices has seen steady growth, projected to reach substantial figures by 2025, significantly influencing the landscape for major companies.

On the mergers and acquisitions front, Abbott Laboratories completed an acquisition of a local firm in April 2023 to bolster its product offerings in occlusion technologies, while Stryker Corporation has been in talks for potential collaborations in the sector to increase market share. Over the past couple of years, the market has also acknowledged increased regulatory support to adopt advanced medical solutions, further propelling advancements within South Korea's healthcare system.

**South Korea Occlusion Devices Market Segmentation Insights**

**Occlusion Devices Market Product****Outlook**

- Occlusion Removal Devices
- Embolization Devices
- Tubal Occlusion Devices
- Support Devices

**Occlusion Devices Market Application****Outlook**

- Neurology
- Cardiology

**Occlusion Devices Market End User****Outlook**

- Hospitals & Clinics

## Market Drivers

### Aging Population

The demographic shift towards an aging population in South Korea significantly influences the occlusion devices market. With an increasing number of elderly individuals, the prevalence of conditions requiring occlusion devices, such as cardiovascular diseases and stroke, is expected to rise. By 2025, it is estimated that over 20% of the South Korean population will be aged 65 and above, creating a substantial demand for medical interventions. This demographic trend suggests that healthcare providers will need to enhance their offerings, including occlusion devices, to cater to the specific needs of older patients. Consequently, the occlusion devices market is likely to experience growth as healthcare systems adapt to the challenges posed by an aging society.

### Increasing Healthcare Expenditure

The rising healthcare expenditure in South Korea is a pivotal driver for the occlusion devices market. As the government and private sectors allocate more funds towards healthcare, the demand for advanced medical devices, including occlusion devices, is likely to increase. In 2025, healthcare spending in South Korea is projected to reach approximately $200 billion, reflecting a growth rate of around 5% annually. This financial commitment enables hospitals and clinics to invest in innovative occlusion devices, enhancing patient care and treatment outcomes. Furthermore, the emphasis on improving healthcare infrastructure and technology adoption supports the expansion of the occlusion devices market. As healthcare providers seek to offer better services, the integration of advanced occlusion devices becomes essential, thereby driving market growth.

### Supportive Regulatory Environment

A supportive regulatory environment in South Korea is instrumental in fostering the growth of the occlusion devices market. The government has established frameworks that facilitate the approval and commercialization of new medical devices, ensuring that innovative products can reach the market efficiently. Regulatory bodies are increasingly streamlining processes, which encourages manufacturers to invest in research and development. This proactive approach not only enhances the availability of advanced occlusion devices but also instills confidence among healthcare providers and patients. As a result, the occlusion devices market is likely to benefit from this conducive regulatory landscape, promoting the introduction of cutting-edge technologies and improving patient care.

### Technological Innovations in Medical Devices

Technological innovations play a crucial role in shaping the occlusion devices market. The continuous development of advanced materials and design improvements enhances the efficacy and safety of occlusion devices. In South Korea, research and development initiatives are increasingly focused on creating devices that offer better performance and patient outcomes. For instance, the introduction of bioresorbable occlusion devices is gaining traction, as they provide temporary occlusion without the need for surgical removal. This innovation aligns with the growing trend towards personalized medicine and tailored treatment options. As these technologies evolve, they are likely to attract investment and drive growth in the occlusion devices market, reflecting the dynamic nature of the healthcare landscape.

### Rising Awareness of Minimally Invasive Procedures

There is a growing awareness and preference for minimally invasive procedures among both healthcare professionals and patients in South Korea. This trend is a significant driver for the occlusion devices market, as these devices are often integral to such procedures. The advantages of minimally invasive techniques, including reduced recovery times and lower risk of complications, are increasingly recognized. As a result, hospitals are more inclined to adopt occlusion devices that facilitate these procedures. Market data indicates that the minimally invasive surgery segment is expected to grow at a CAGR of 7% through 2025, further propelling the demand for occlusion devices. This shift in surgical practices underscores the importance of innovation in the occlusion devices market.

## Future Outlook

The [Occlusion Devices Market](https://www.marketresearchfuture.com/reports/occlusion-devices-market-5934) is projected to grow at a 5.29% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of vascular diseases, and rising healthcare expenditure.

**New opportunities:**

- Development of advanced biodegradable occlusion devices for enhanced patient safety.
- Expansion into telemedicine platforms for remote monitoring of occlusion device performance.
- Strategic partnerships with healthcare providers for integrated treatment solutions.

By 2035, the occlusion devices market is expected to achieve substantial growth, reflecting evolving healthcare needs.

## Segment Insights

### By Product: Embolization devices (Largest) vs. Support devices (Fastest-Growing)

In the South Korea occlusion devices market, embolization devices hold the largest share among the product segments, attributed to their extensive use in various minimally invasive procedures. Support devices follow as a significant component, demonstrating strong adoption across medical facilities. While occlusion removal devices remain essential, they are overshadowed by the rising demand for more innovative and efficient embolization and support solutions.

Growth trends in this segment are driven by advancements in technology and an increasing prevalence of targeted therapies. The shift towards minimally invasive techniques enhances the appeal of embolization devices, while support devices are gaining traction due to their ability to facilitate complex procedures. The emergence of new therapies and enhancements in device safety and efficacy are expected to provide further impetus to these segments in the coming years.

Embolization devices (Dominant) vs. Support devices (Emerging)

Embolization devices are recognized as the dominant force in the South Korea occlusion devices market, meticulously designed for precise delivery of therapeutic agents in vascular procedures. Their proven effectiveness in treating conditions such as tumors and vascular malformations solidifies their position. In contrast, support devices are emerging as vital tools, enhancing procedural efficacy and patient outcomes. These devices, including balloons and stents, are designed to support or maintain patency during and after occlusion therapies. Their growing utilization is fueled by advancements in materials and design, ensuring enhanced safety and usability. Together, these segments reflect the dynamic nature of the occlusion devices landscape, catering to the evolving needs of healthcare providers and patients alike.

### By Application: Cardiology (Largest) vs. Oncology (Fastest-Growing)

In the South Korea occlusion devices market, cardiology remains the largest segment, commanding a significant share due to the high prevalence of cardiac disorders. This segment's strong market position is bolstered by advanced technological innovations and increasing investments in cardiology-related medical devices. Peripheral vascular disease and urology are also important segments, contributing to the overall market stability, but they do not match the dominance of cardiology.

Oncology is emerging as the fastest-growing segment, driven by an increasing incidence of cancer and growing awareness about early detection and treatment options. The incorporation of minimally invasive techniques and advancements in therapeutic solutions are further propelling this segment's growth. Additionally, the supportive healthcare policies in South Korea aim to enhance cancer care services, fostering accelerated market expansion in oncology.

Cardiology: Dominant vs. Oncology: Emerging

Cardiology stands out as the dominant application segment in the South Korea occlusion devices market, primarily due to the rising prevalence of cardiovascular diseases and ongoing technological advancements in diagnostic and therapeutic devices. Market players in this segment are focusing on innovative solutions to enhance patient outcomes, such as cutting-edge occlusion devices that facilitate minimally invasive surgeries. Conversely, oncology is emerging as a vital segment, driven by an upsurge in the number of cancer cases and a heightened focus on targeted therapies. This segment benefits from increased funding and research in cancer treatments, leading to the development of sophisticated occlusion devices specifically designed to cater to oncological applications. Together, these segments exemplify the diverse needs and technological advancements in the South Korea occlusion devices landscape.

### By End-User: Hospitals (Largest) vs. Clinics (Fastest-Growing)

In the South Korea occlusion devices market, hospitals dominate the end-user segment, accounting for a significant portion of the overall market share. Clinics and diagnostic centers follow, but their shares are notably smaller. Other end-users represent a niche but important part of the market, as they increasingly adopt occlusion devices for varied applications. Overall, the distribution showcases that while hospitals are the mainstay, emerging players are gaining traction especially in specialized clinics.

The growth trends within this segment reveal an upward trajectory, particularly driven by advancements in medical technology and an increase in awareness regarding minimally invasive procedures. Hospitals continue to invest heavily in advanced occlusion devices, while clinics are rapidly expanding their capabilities to meet patient demand, establishing themselves as the fastest-growing segment. Rising healthcare expenditure and the increasing prevalence of chronic diseases are further amplifying this growth trend across all user types.

Hospitals (Dominant) vs. Clinics (Emerging)

Hospitals are the dominant users of occlusion devices, showcasing robust integration of these technologies into surgical and interventional procedures. Their large-scale operations enable them to leverage economies of scale in procurement, ensuring access to the latest advancements in occlusion technology. Meanwhile, clinics are emerging rapidly, driven by the need for specialized treatments and patient preferences for less invasive options. This trend is particularly evident in urban areas where clinics are adopting innovative devices to expand their service offerings. Both segments are essential in shaping the landscape of the South Korea occlusion devices market, with hospitals focusing on comprehensive healthcare solutions while clinics pursue agile, patient-centered services.

### Occlusion Devices Market End User Insights

Occlusion Devices Market End User Insights

The End User segment of the South Korea Occlusion Devices Market is prominently characterized by the critical roles of hospitals and clinics in patient care and treatment procedures. As vital components of the healthcare ecosystem, these facilities are at the forefront of implementing occlusion devices, which are essential for various medical applications such as vascular surgeries, interventional radiology, and cardiology.

The integration of advanced occlusion devices in these medical settings significantly enhances the efficacy of treatment protocols and patient outcomes.Furthermore, the rise in surgical procedures alongside a growing incidence of vascular diseases contributes greatly to the demand from hospitals and clinics, ensuring their pivotal role in the South Korea Occlusion Devices Market.

## Competitive Benchmarking

The [occlusion devices market](https://www.marketresearchfuture.com/reports/occlusion-devices-market-5934) in South Korea is characterized by a competitive landscape that is both dynamic and multifaceted. Key growth drivers include an increasing prevalence of chronic diseases, advancements in medical technology, and a growing emphasis on minimally invasive procedures. Major players such as Medtronic (US), Boston Scientific (US), and Abbott Laboratories (US) are strategically positioned to leverage these trends. Medtronic (US) focuses on innovation through continuous product development, while Boston Scientific (US) emphasizes strategic partnerships to enhance its market reach. Abbott Laboratories (US) is actively pursuing regional expansion, particularly in Asia, to capitalize on emerging market opportunities. Collectively, these strategies contribute to a competitive environment that is increasingly shaped by technological advancements and collaborative efforts.
In terms of business tactics, companies are localizing manufacturing to reduce costs and improve supply chain efficiency. The market structure appears moderately fragmented, with several key players holding substantial market shares. This fragmentation allows for a diverse range of products and innovations, although it also intensifies competition among established and emerging firms. The collective influence of these key players is significant, as they drive market trends and set benchmarks for quality and innovation.
In October 2025, Medtronic (US) announced the launch of its latest occlusion device, which incorporates advanced imaging technology to enhance procedural accuracy. This strategic move is likely to strengthen Medtronic's position in the market by addressing the growing demand for precision in medical procedures. The introduction of this device not only showcases Medtronic's commitment to innovation but also reflects a broader trend towards integrating advanced technologies in healthcare solutions.
In September 2025, Boston Scientific (US) entered into a partnership with a leading South Korean healthcare provider to co-develop new occlusion devices tailored to local market needs. This collaboration is indicative of Boston Scientific's strategy to enhance its product offerings through localized solutions, thereby increasing its competitive edge in the region. Such partnerships may also facilitate faster market entry and better alignment with regulatory requirements, which are crucial in the medical device sector.
In August 2025, Abbott Laboratories (US) expanded its manufacturing capabilities in South Korea, investing approximately $50 million in a new facility dedicated to the production of occlusion devices. This expansion is a clear indication of Abbott's commitment to meeting the rising demand in the Asia-Pacific region. By enhancing its production capacity, Abbott is likely to improve its supply chain reliability and responsiveness to market changes, which are essential in maintaining a competitive advantage.
As of November 2025, current trends in the occlusion devices market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) in product development. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and enhancing market presence. Looking ahead, competitive differentiation is expected to evolve, with a notable shift from price-based competition towards a focus on innovation, technological advancements, and supply chain reliability. This transition may redefine how companies position themselves in the market, emphasizing the importance of quality and cutting-edge solutions over mere cost considerations.

## Recent News & Developments

In recent months, the South Korea Occlusion Devices Market has experienced notable developments and dynamics influencing its growth. Companies such as Medtronic, Aesculap, and Johnson and Johnson have been focusing on innovative product lines and technologies tailored for occlusion solutions. For instance, in June 2023, Medtronic announced an expansion of its product range specifically targeting vascular occlusion, which is expected to enhance treatment outcomes in the region.

Additionally, in August 2023, updates from Cook Medical and LivaNova highlighted advancements in device manufacturing processes, aiming to improve efficiency and patient safety. The market valuation for occlusion devices has seen steady growth, projected to reach substantial figures by 2025, significantly influencing the landscape for major companies.

On the mergers and acquisitions front, Abbott Laboratories completed an acquisition of a local firm in April 2023 to bolster its product offerings in occlusion technologies, while Stryker Corporation has been in talks for potential collaborations in the sector to increase market share. Over the past couple of years, the market has also acknowledged increased regulatory support to adopt advanced medical solutions, further propelling advancements within South Korea's healthcare system.

## Report Scope

| MARKET SIZE 2024 | 92.14(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 97.01(USD Million) |
| MARKET SIZE 2035 | 162.5(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.29% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Terumo Corporation (JP), B. Braun Melsungen AG (DE), Johnson & Johnson (US), Stryker Corporation (US), Cook Medical (US) |
| Segments Covered | Product, Application, End-User |
| Key Market Opportunities | Advancements in minimally invasive techniques drive growth in the occlusion devices market. |
| Key Market Dynamics | Rising demand for minimally invasive procedures drives innovation in occlusion devices within South Korea's healthcare sector. |
| Countries Covered | South Korea |

## Frequently Asked Questions

**Q: What is the current valuation of the occlusion devices market in South Korea as of 2024?**
A: The market valuation was $92.14 Million in 2024.

**Q: What is the projected market size for occlusion devices in South Korea by 2035?**
A: The projected valuation for 2035 is $162.5 Million.

**Q: What is the expected CAGR for the South Korea occlusion devices market during the forecast period 2025 - 2035?**
A: The expected CAGR is 5.29% during the forecast period 2025 - 2035.

**Q: Which product segment had the highest valuation in 2024 within the occlusion devices market?**
A: The Support devices segment had the highest valuation at $40.0 Million in 2024.

**Q: What is the valuation range for embolization devices in the South Korea occlusion devices market?**
A: The valuation range for embolization devices is between $30.0 Million and $52.0 Million.

**Q: Which application segment is projected to grow the most by 2035 in the occlusion devices market?**
A: The Oncology application segment is projected to grow to between $25.0 Million and $40.0 Million by 2035.

**Q: What is the expected valuation for urology applications in the occlusion devices market by 2035?**
A: The expected valuation for urology applications is projected to be between $15.0 Million and $25.0 Million by 2035.

**Q: Which end-user segment had the lowest valuation in 2024 for occlusion devices?**
A: The Others end-user segment had the lowest valuation at $17.14 Million in 2024.

**Q: Who are the key players in the South Korea occlusion devices market?**
A: Key players include Medtronic, Boston Scientific, Abbott Laboratories, and Terumo Corporation.

**Q: What is the valuation range for occlusion removal devices in the market?**
A: The valuation range for occlusion removal devices is between $22.14 Million and $40.5 Million.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-occlusion-devices-market-55009*